• From Histone Marks to Protein Readouts in Bone Biology

  2026-10-06

  A translational perspective on how prenatal dexamethasone reshapes osteoprogenitor biology through Mkp-1 regulation, and how thoughtful lysate strategy can strengthen mechanistic protein readouts without overstating what a buffer can prove.

• Haloprogin: Reading Antifungal Evidence Correctly

  2026-10-06

  Haloprogin combines dermatophyte, yeast, and selective Gram-positive antibacterial activity, but its evidence is best understood through endpoint context and translational limits. This article examines the compound’s chemistry, comparative data, mechanism uncertainty, and research value without treating historical findings as universal clinical conclusions.

• CAY10499 and the Lipid Logic of TAM Reprogramming

  2026-10-05

  The emerging link between extracellular-vesicle ACLY transfer, lipid remodeling, and tumor-associated macrophage function creates a rationale for separating lipogenesis from lipid hydrolysis in translational research. This article positions CAY10499 as a research probe for HSL/MGL biology while defining its evidence boundaries, assay interpretation risks, and relevance to HCC immunometabolism.

• LY2228820: From p38 Mechanism to Translation

  2026-10-05

  A source-grounded perspective on how LY2228820 can support mechanism-first cancer and inflammation research, while integrating p38 pathway biology with multiomics, evidence boundaries, and translational decision-making.

• SUMO Protease (Ulp) Product Overview

  2026-10-04

  APExBIO’s SUMO Protease (Ulp), SKU K1103, is a recombinant Ulp1 protease described for conceptual removal of compatible SUMO fusion tags. No matched paper evidence is available, so performance claims remain supplier-documented.

• CRISPR Rabbit Pharming: Evidence and Limits

  2026-10-03

  Song et al. report a targeted rabbit knock-in strategy using the native CSN2 promoter to drive milk expression of tdTomato, with homozygous animals reaching a reported 15–20 g/L recombinant protein concentration. The study is a proof of concept for promoter-guided, heritable expression in rabbit pharming, but it does not establish equivalent performance for therapeutic proteins or implicate HEPES and pH regulation in the reported outcome.

• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-10-02

  Build a sensitive, flexible Western blot workflow for low-abundance targets on nitrocellulose or PVDF membranes. This guide combines practical optimization of horseradish peroxidase (HRP) chemiluminescence with a translational assay strategy inspired by a urine nanosensor study of early atherosclerosis.

• Cy3 NHS ester (non-sulfonated): Labeling Guide

  2026-10-01

  Cy3 NHS ester (non-sulfonated) provides an orange fluorescent handle for labeling accessible amino groups on proteins, peptides, and amino-modified oligonucleotides or DNA. It is appropriate when DMSO or DMF can be tolerated, but it is not suitable for water-only labeling, solvent-sensitive biomolecules, or long-term storage as a solution.

• Caspase-3 Fluorometric Assay Kit: Workflow Guide

  2026-10-01

  Turn DEVD-dependent caspase-3 activity into a quantitative apoptosis readout with a fast fluorometric workflow. This guide shows how to use the assay in conventional apoptosis studies and how to interpret it alongside ferroptosis–apoptosis crosstalk, PARP1 biology, and disease-focused models.

• Bifurcated ROS Sensing by TRPV1 and TRPA1

  2026-09-30

  A 2026 Redox Biology study shows that TRPV1 and TRPA1 distinguish singlet oxygen from hydrogen peroxide through different channel- and residue-dependent mechanisms. The findings establish carvacrol as a useful non-electrophilic TRPA1 comparator and refine how reactive oxygen species can shape sensory ion-channel activity.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-09-30

  A 2025 study links berberine to suppression of senescence-associated secretory phenotype inflammation through an RXRα/PPARγ/NEDD4 axis in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse pathology, foam-cell experiments, Smart-seq analysis, and macrophage-targeted RXRα knockdown provides a mechanistic framework connecting nuclear-receptor signaling with ubiquitin-dependent regulation of the GATA4/p62 complex.

• Reversible Epiblast Regionalization in hPSCs

  2026-09-29

  This study shows that human pluripotent stem cell differentiation bias can arise from reversible anterior–posterior epiblast-like regionalization and locus-specific erosion of bivalent chromatin, rather than DNA methylation changes alone. Its chemical chromatin restoration strategy recovered anterior-like molecular features, neural organoid competence, and broader germ-layer differentiation, offering a framework for evaluating and rescuing compromised hPSC lines.

• Mechanical Stress, Autophagy, and Cytoskeletal Control

  2026-09-29

  The reference study shows that compression-induced autophagy depends primarily on actin-containing microfilaments, while microtubules provide an auxiliary contribution. Its combination of cytoskeletal perturbation, fluorescence-based analysis, and western blotting offers a useful framework for studying how mechanical inputs are converted into autophagic responses.

• RNase Alert-Plus: RNA Integrity Control

  2026-09-28

  RNase Alert-Plus is an RNA workflow control associated with SKU K1903. It can help frame RNase-related testing, but the supplied product dossier does not specify its reporter chemistry, operating conditions, or acceptance limits; those parameters should come from the current product instructions.

• Sulfo-NHS-Biotin for Host–Pathogen Assay Design

  2026-09-28

  Sulfo-NHS-Biotin can add a surface-accessibility layer to host–pathogen experiments without being confused with a functional perturbation. This article connects its chemistry to the findings on GSK3 inhibition in tuberculosis and clarifies what biotinylation can—and cannot—show.

8068 records 1/538 page Next 12345 下5页 Last page